dasatinib + chemotherapy ABL1 Fusion, +7 more biomarkers B-Cell Acute Lymphoblastic Leukemia Consolidation, +1 more context chemotherapy, +1 more drug chemotherapy, +1 more type
midostaurin +/- induction therapy FGFR1 Fusion Myeloid/Lymphoid Neoplasms with Eosinophilia and Gene Rearrangement induction therapy, +1 more drug Other, +1 more type
pemigatinib +/- induction therapy FGFR1 Fusion Myeloid/Lymphoid Neoplasms with Eosinophilia and Gene Rearrangement induction therapy, +1 more drug Other, +1 more type
ponatinib +/- induction therapy FGFR1 Fusion Myeloid/Lymphoid Neoplasms with Eosinophilia and Gene Rearrangement induction therapy, +1 more drug Other, +1 more type